CHT’s Healthy Columbus Initiative
| Date: April 25, 2007 | Location: Columbus, GA |
The CHT team consisting of Founder Newt Gingrich, CEO Nancy Desmond, Georgia Project Director Laura Linn, Project Director Wayne Oliver, Assistant Jennifer Cunningham and Fellow Terry Womack spent the day in Columbus Georgia to discuss the expansion of the Columbus Project, which is being conducted in partnership with Dr. Steven Leichter and the Columbus Research Foundation.
At the Columbus Rotary Club meeting Newt spoke to a crowd of over 450 about the opportunity for Columbus to lead the nation by developing a community model of health. Dr. Elizabeth Martin was presented with the NCQA Diabetes Certificate of Recognition by Newt and honored as the 100th physician in Georgia to attain DPRP recognition. The Columbus Project goals and programs were discussed in greater detail at a follow-up meeting with Columbus community leaders. The group heard from Newt; Dr. Steven Leichter, Director of the Columbus Research Foundation; Julia Portale, Senior Director of Pfizer Health Solutions; and Mike Mawby, Chief Government Affairs Officer for Novo Nordisk.
Newt Gingrich Speech at the Columbus Rotary Club
“The Opportunity Before Us”
CHT Founder Newt Gingrich presents the NCQA Diabetes Certificate of Recognition to Dr. Elizabeth Martin of Columbus, Georgia. Dr. Martin is the 100th physician in Georgia to be recognized through the NCQA Diabetes Physician Recognition Program. [Photo credit – Laura Linn of the Center for Health Transformation 4/25/07]
Newt & Dr. Steven Leichter met with over 50 community leaders to discuss the Healthy Columbus Initiative.
Dr. Steven Leichter – Medical Director of the Columbus Research Foundation, Renee Spencer – Certified Clinical Research Coordinator, Brooke Jones –Manager of the Columbus Project, and Andrea Giammona – Foundation Administrator
More photos from the Rotary Club Event courtesy of Camera 1 >>
Columbus Georgia Community Leaders Meeting Handout:
- Newt – “The Opportunity Before Us”
- Dr. Steven Leichter, Columbus Research Foundation – “The Columbus Project”
- Mike Mawby, Novo Nordisk – "Medicare Screening Initiative"
